Neurol. praxi. 2013;14(1):46-50

Chlamydophila pneumoniae and multiple sclerosis

MUDr.Jan Galský, Ph.D., MBA
Infekční oddělení, Nemocnice Mělník

Chlamydophila pneumoniae is an intracellular pathogen and important cause of respiratory tract infection. Monocytes may traffic Chlamydophila

pneumoniae across the blood-brain-barrier but there is a strong evidence that Chlamydophila pneumoniae has not causal

role in multiple sclerosis. Chlamydiae are susceptible to antibiotics that afect DNA and protein synthesis, including macrolides, azalide,

specifically azithromycin, tetracyklines, and chinolones. Long-term antibiotic treatment of chronic disaeses, such as multiple sclerosis,

Alzheimer´s disease, asthma, atherosclerosis, is unlikely show any benefit.

treatment:

Keywords: chlamydiae, Chlamydophila pneumoniae, Chlamydophila pneumoniae and multiple sclerosis, chlamydiae and chronic sequalae,

Published: March 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Galský J. Chlamydophila pneumoniae and multiple sclerosis. Neurol. praxi. 2013;14(1):46-50.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bagos PG, Nikolopoulos G, Ioannidis A. Chlamydia pneumoniae infection and risk of multiple sclerosis: a meta-analysis. Mult Scler. 2006; 12(4): 397-411. Go to original source... Go to PubMed...
    2. Cerome MC, Ma JJ, Stephens RS. Cloning and sequence of the gene for heat shock protein 60 from Chlamyda trachomatis and immunological reaktivity of the protein. Infect Immunol 1991; 59: 79-90. Go to original source... Go to PubMed...
    3. Contini C, Seraceni S, Cultrera R, Castellazzi M. Review Article. Chlamydophila penumoniae Infection and Its Role in Neurological Disorders. Interdisciplinary Perspectives on Infectious Diseases. 2010, Article ID 273573, 18 pages. Go to original source...
    4. Everett KDE, Bush RM, Andersen AA. Emended description of the order Chlamydiales proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam.nov., each containing one monotypic genus, revise taxonomy of the family hlamydiaceae, including a new genus and five new species, and standards for the identification of organismus. International Journal of Systematic Bakteriology 1999; 49: 415-440. Go to original source... Go to PubMed...
    5. Flockhart DA. Drug Interactions: Cytochrome P450 Drug Interaction Table. Indiana University School of Medicine (2007). http://medicine.iupui.edu/clinpharm/ddis/table.aspx. Accessed [date].
    6. Forsgren A, Riesbeck K. Antibiotics and immune system. In: Finch RG, Greenwood D, Norrby AR, Whitley RJ. Antibiotics and chemotherapy. Saunders Elsevier, e-edition 2010. Go to original source...
    7. Galský J. Chlamydie - diagnostika a terapie. Postgraduální medicína 2011; 13(4): 368-377.
    8. Galský J, Hobstová J. Chlamydiové infekce - diagnostika a léčba. Vydán: únor 2012. http://www.infekce.cz/DopChlam12.htm.
    9. Gurčík L. Primárne progresívna roztrúsená skleróza - diagnostika, klinické aspekty a liečba. Neurol. praxi 2011; 12(5): 321-328.
    10. Hammerschlag MR, Kohlhoff SA, Apfalter PM. Chlamydophila (Chlamyda) pneumonie. In Mandel GL, Bennett JE, Dolin R: Principles and practice of infectious diseases, 7th e-edition. Philadelphia: Churchill Livingstone Elsevier, 2010.
    11. Havrdová E. Roztroušená skleróza: zánět nebo neurodegenerace? Neurol. praxi, 2007; 2: 99-101.
    12. Horáková D. Rotroušená skleróza - naše současné možnosti při diagnostice, stanovení prognózy nemoci a sledování aktivity léčby. Neurol. praxi 2011; 13(4): 265-269.
    13. Kaufman M, Gaydos CA, Sriram S, Boman J, Tondella ML,Norton HJ. Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results. Mult Scler. 2002; 8(4): 289-294. Go to original source... Go to PubMed...
    14. MacIntyre A, Abramov R, Hammond CJ, Hudson AP, Arking EJ, Little CS, Appelt DM, Balin BJ. Chlamydiae pneumonie infection promotes the transmigration of monocytes through human brain endothelial cells. Journal of Neuroscience Research. 2003; 71(5): 740-750. Go to original source... Go to PubMed...
    15. Myers GSA, Mathews SA, Eppinger M, Mitchell. O´Brien KK, White OR, Benahmed F, Brunham RC, read TD, Ravel J, Bavoil PM, Timms P. Evidence that human Chlamydia pneumoniae was zoonotically acquired. Journal of Bakteriology, Dec. 2009: 7225-7233. Go to original source... Go to PubMed...
    16. Pawate S, Sriram S. The role of infections in the pathogenesis and course of multiple sclerosis. Ann Indian Acad Neurol, 2010; 13(2): 80-86. Go to original source... Go to PubMed...
    17. Riska PF, Kutlin A, Ajibove P, Cua A, Roblin PM, Hammerschlag MR. Genetic and culture-based approaches for detecting macrolide resistence in Chlamydia pneumoniae. Antimicrob Agents Chemother 2004; 48: 3586-3690. Go to original source... Go to PubMed...
    18. Rupp PF, Gebert A, Solbach W, Maass M.. Serine-to-asperagine substitution in the GyrA gene leads to quinolone resistence in moxifloxacin-exposed Chlamydia pneumoniae. Antimicrob Agents Chemother 2005; 49: 406-407. Go to original source... Go to PubMed...
    19. Yucesan C, Sriram S. Chlamydie pneumonie infection of the central nervous systém. Curr Opin Neurol. 2001; 14(3): 355-359. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.